We are live on ! Find out more
COGT icon

Cogent Biosciences
COGT

135 hedge funds and large institutions have $886M invested in Cogent Biosciences in 2023 Q3 according to their latest regulatory filings, with 12 funds opening new positions, 58 increasing their positions, 36 reducing their positions, and 13 closing their positions.

New
Increased
Maintained
Reduced
Closed

242% more call options, than puts

Call options by funds: $940K | Put options by funds: $275K

61% more repeat investments, than reductions

Existing positions increased: 58 | Existing positions reduced: 36

20.62% more ownership

Funds ownership: 85.69% → 106.31% (+21%)

0% more funds holding in top 10

Funds holding in top 10: 7 → 7 (0)

1% less funds holding

Funds holding: 136 → 135 (-1)

8% less first-time investments, than exits

New positions opened: 12 | Existing positions closed: 13

15% less capital invested

Capital invested by funds: $1.05B → $886M (-$162M)

Holders
135
Holders Change
-1
Holders Change %
-0.74%
% of All Funds
2.14%
Holding in Top 10
7
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.11%
New
12
Increased
58
Reduced
36
Closed
13
Calls
$940K
Puts
$275K
Net Calls
+$665K
Net Calls Change
+$444K

Top Buyers

1
Fidelity Investments
Fidelity Investments
Massachusetts
+$50.4M
2
SCM
Suvretta Capital Management
New York
+$9.89M
3
BlackRock
BlackRock
New York
+$7.94M
4
SVCM
Saturn V Capital Management
Texas
+$7.5M
5
KCM
Kynam Capital Management
New Jersey
+$7.03M

Top Sellers

1
DM
Deerfield Management
New York
-$27M
2
EAM
Eventide Asset Management
Massachusetts
-$15.3M
3
FCM
Farallon Capital Management
California
-$11.5M
4
Point72 Asset Management
Point72 Asset Management
Connecticut
-$10.9M
5
LGM
Logos Global Management
California
-$9.47M
Name Holding Trade Value Shares
Change 		Change in
Stake
Nisa Investment Advisors
126
Nisa Investment Advisors
Missouri
$17.8K +$9.14K +771 +73%
RTL
127
Red Tortoise LLC
Georgia
$3.33K – – –
Daiwa Securities Group
128
Daiwa Securities Group
Japan
$3K – – –
LC
129
Lindbrook Capital
California
$2.64K +$747 +63 +30%
US Bancorp
130
US Bancorp
Minnesota
$2.39K -$2.23K -188 -43%
NFSG
131
Newbridge Financial Services Group
Florida
$1.19K – – –
BAAM
132
Baker Avenue Asset Management
California
$205 – – –
Osaic Holdings
133
Osaic Holdings
Arizona
$166 – – –
AF
134
Allworth Financial
California
$117 +$142 +12 New
LGM
135
Logos Global Management
California
– -$9.47M -800,000 Closed
TLP
136
Tri Locum Partners
New York
– -$792K -66,885 Closed
MIM
137
Monashee Investment Management
Massachusetts
– -$592K -50,000 Closed
E
138
Ergoteles
New York
– -$574K -48,501 Closed
EGM
139
Engineers Gate Manager
New York
– -$320K -27,019 Closed
V
140
Veritable
Delaware
– -$205K -17,331 Closed
AQR Capital Management
141
AQR Capital Management
Connecticut
– -$161K -13,633 Closed
ZIM
142
Zacks Investment Management
Illinois
– -$154K -13,000 Closed
EFM
143
E Fund Management
China
– -$131K -11,088 Closed
LSA
144
Leonteq Securities AG
Switzerland
– -$82.9K -7,000 Closed
Allspring Global Investments
145
Allspring Global Investments
North Carolina
– -$5.14K -434 Closed
GRP
146
Global Retirement Partners
California
– -$1.43K -121 Closed
ODG
147
O'Dell Group
Ohio
– -$415 -35 Closed
C
148
Covestor
United Kingdom
– -$12 -1 -13%
2 3 4 5
6

COGT Hedge Fund Activity: Q3 2023 in Review

135 of the 6,301 institutional investors tracked by Wall St. Rank reported a position in Cogent Biosciences (COGT) for Q3 2023, worth a combined $886M — down 15% from $1.05B a quarter earlier.

Sellers outnumbered buyers: 13 funds closed out of COGT and 12 opened new positions — a net loss of 1 holder — while 36 trimmed existing stakes and 58 added.

The largest buyer was Fidelity Investments, adding an estimated $50.4M. The largest seller was Deerfield Management, cutting an estimated $27M.

  • 135 institutional investors held Cogent Biosciences (COGT) as of Q3 2023, down from 136 in Q2 2023.
  • Funds reported $886M of Cogent Biosciences stock for Q3 2023, down 15% quarter-over-quarter.
  • 12 funds opened new Cogent Biosciences positions in Q3 2023 and 13 closed out, a net change of -1 holder.
  • The largest Cogent Biosciences buyer in Q3 2023 was Fidelity Investments, an estimated $50.4M added.
  • The largest Cogent Biosciences seller in Q3 2023 was Deerfield Management, an estimated $27M sold.

Based on aggregated 13F filings for Q3 2023.